Episode 73: The Science of Longevity

Nicholas Schork, Ph.D.

Nicholas Schork, Ph.D.

Distinguished Professor and Co-Director
Clinical Genomics and Therapeutics Division

View Profile

Aging. It’s something we’d all like to do better. 

Americans spend an estimated $5 Billion on anti-aging products every year. But at TGen and City of Hope, scientists like TGen distinguished professor Nicholas Schork, Ph.D., are working to unlock the secrets to not just better ‘aging,’ but disease prevention alongside longevity, and are making promising progress toward medications and methods that will be tailored to each specific person, rather than those that promise longer healthier lives for all.  

In this episode of 
TGen Talks, our host Karie Dozer sits down with Schork to discuss the groundbreaking search for substances that can slow down aging. Imagine a daily pill that not only extends your lifespan but also your health span, delaying age-related diseases like heart disease, diabetes, and cancer. Schork, with his extensive background in quantitative genetics and translational biomedical science, explains the exciting potential of longevity and health promoting interventions, termed ‘geroprotectors,’ and the race to develop them.

We'll explore the challenges and excitement of developing anti-aging interventions, the race to find effective solutions, and the potential of personalized treatments through “N-of-1” trials. Join us as we delve into the future of aging research and the hope it brings for healthier, longer lives.